HealX
Latest round
- Series C
Last raised
- Jul 2024
Total raised
- $114M
Investors
- 10
About HealX
Founded in 2014 and headquartered in Cambridge, UK, HealX Ltd. focuses on drug discovery for rare diseases. The company has undergone a strategic pivot towards utilizing artificial intelligence in its operations. In July 2025, HealX Ltd.HealX specializes in AI-driven drug discovery, targeting over 10,000 rare diseases affecting around 300 million people globally who lack effective treatments. The company offers a comprehensive drug development platform that facilitates the identification of potential drug-disease relationships, expediting the transition of therapies from prediction to clinical application.In 2023, HealX reported zero revenue and an EBITDA of USD -21,727,815. The company's revenue is primarily generated through strategic partnerships with pharmaceutical firms and research institutions, facilitating co-development and commercialization of drug candidates. These partnerships typically involve B2B agreements involving milestone payments or royalties, aligning with industry standards for rare disease therapies.
Who invested in HealX
10 investors across 4 rounds
See all investors in HealX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HealX
Who invested in HealX?
HealX has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HealX raised?
HealX has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did HealX last raise money?
HealX's most recent round on record is a Series C, in Jul 2024.
What does HealX do?
Founded in 2014 and headquartered in Cambridge, UK, HealX Ltd.
Where is HealX headquartered?
HealX is headquartered in Cambridge, UK.
Which VCs invest in companies like HealX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at HealX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like HealX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.